PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Immersive experience will equip clinicians with the skills to harness AI in cardiovascular medicine

2025-09-16
(Press-News.org) NEW YORK AND NAPLES, FL – September 15, 2025 – The Cardiovascular Research Foundation® (CRF®) and Jon DeHaan Foundation today announced the launch of the TCT AI Lab, a groundbreaking new program debuting at TCT® 2025, October 25–28 at the Moscone Center in San Francisco.

The TCT AI Lab is a first-of-its-kind destination dedicated to integrating artificial intelligence into clinical practice. Over three intensive days, clinicians will progress from the fundamentals of AI to hands-on clinical applications – guided by leading innovators at the forefront of digital medicine.

“AI is transforming medicine, and cardiology is no exception,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF®. “The TCT AI Lab will give clinicians not just a window into this future, but the skills and confidence to lead it – advancing precision, efficiency, and better outcomes for patients worldwide.”

This transformative initiative is made possible through a generous grant from the Jon DeHaan Foundation, whose longstanding commitment to innovation continues to shape the future of cardiovascular care.

“The Jon DeHaan Foundation is proud to support the TCT AI Lab, which represents a bold step forward in equipping clinicians to embrace AI,” said Robert Schwartz, MD, President of the Jon DeHaan Foundation. “We believe that empowering physicians through education and training is essential to driving innovation and improving patient outcomes.”

“We are deeply grateful to the Jon DeHaan Foundation for their visionary partnership. Together, we are helping clinicians not just keep pace with change, but lead the transformation of cardiovascular care,” Dr. Granada added.

Inside the TCT AI Lab

Powered by CRF® & the Jon DeHaan Foundation

Sunday, October 26 – Tuesday, October 28

Participants will take part in an immersive curriculum combining lectures, tutorials, and interactive demonstrations:

AI Fundamentals for Clinicians
Build a strong foundation in AI concepts, understand algorithmic architecture, and gain the confidence to evaluate and apply AI tools. Real-World Applications
Explore how AI is already revolutionizing cardiovascular care from ECG analysis and coronary artery disease diagnosis to imaging interpretation and patient reporting. Hands-On Tutorials
Engage directly with the platforms and technologies driving AI innovation in clinical settings. More information is available at: https://www.tctconference.com/tct-ai-lab.

About CRF® and TCT® 

The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF®’s centers of excellence include the CRF® Skirball Center for Innovation, CRF® Clinical Trials Center, CRF® Center for Education, CRF® Digital, TCTMD®, and Structural Heart: The Journal of the Heart Team. 

Transcatheter Cardiovascular Therapeutics® (TCT®) is the annual scientific symposium of CRF® and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Anchored in a legacy spanning over three decades, TCT® is a world-class educational experience featuring disruptive innovation, scientific breakthroughs, expert-led tutorials, hands-on training, and ample opportunities for networking and collaboration.

For more information, visit www.crf.org and www.tctconference.com.

About the Jon DeHaan Foundation

The Jon Holden DeHaan Foundation, DBA the Jon DeHaan Foundation, provides grants and funding to individuals and companies focused on advancing treatments in cardiovascular medicine. Since 2018, the Foundation has recognized outstanding med-tech innovations with its Award for Innovation in Cardiology. This award provides funding to those who exemplify excellence and whose technological developments will have a significant impact on cardiovascular disease prevention, diagnosis, treatment, or rehabilitation. This program is open to academic and health professionals, as well as engineers, business professionals, and med-tech companies. Applicants must have the intent to commercialize their research.

For more information, visit www.jondehaanfoundation.org.

###

 

END



ELSE PRESS RELEASES FROM THIS DATE:

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

2025-09-15
Simon Fraser University’s Burnaby campus is once again home to Canada’s most powerful academic supercomputer, following the installation of a new system, named Fir. The new Fir system replaces the Cedar supercomputer, housed at the Cedar Supercomputing Centre (the Centre) at SFU. Fir is ranked number 78 in the TOP500 list of the world’s most powerful supercomputers, the only Canadian system in the top 100 worldwide. “The new Fir supercomputer represents a much needed, major upgrade to the national Canadian computing infrastructure,” says ...

Architecture’s past holds the key to sustainable future

2025-09-15
Modern ‘sustainable’ innovations in architecture are failing to slow climate change,  but revisiting ancient knowledge and techniques found in traditional architecture could offer better solutions. This is the argument of architectural historians Professor Florian Urban and Barnabas Calder in their new book Form Follows Fuel: 14 Buildings from Antiquity to the Oil Age. The authors argue that energy availability has been the biggest influence in architecture throughout human history. Their extensive ...

Laser correction for short-sightedness is safe and effective for older teenagers

2025-09-15
Copenhagen, Denmark: A major study of laser correction for short-sightedness shows that the procedure is as safe and effective in older teenagers as it is in adults, according to research presented today (Tuesday) at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). [1]   Short-sightedness, or myopia, affects around a third of children and teenagers and research suggests that it is becoming more common.   A laser treatment, called photorefractive keratectomy (PRK), is widely used to treat myopia in adults but questions remain over its use in teenagers.   The new study was presented by Dr Avinoam Shye, from the Department of Ophthalmology ...

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

2025-09-15
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) shows that some individuals who are taking Ozempic, Wegovy or Mounjaro find that foods taste sweeter or saltier than before. About one in five of those participating in the real-word study, published in the journal Diabetes, Obesity and Metabolism, perceived sweetness more intensely and a similar number were more sensitive to salt – and these changes were linked to a reduction in appetite. “Incretin-based therapies such as Ozempic, Wegovy and Mounjaro are widely used for weight management ...

Taking semaglutide turns down food noise, research suggests

2025-09-15
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) shows that individuals who are taking semaglutide for weight loss experience less food noise than before. Food noise refers to obsessive and intrusive thoughts about food and eating.  This preoccupation with food can hinder healthy lifestyle implementation and lead to overeating, making weight loss difficult. Previous research has found that 57% of people who have living ...

Type 2 diabetes may double risk of sepsis, large community-based study suggests

2025-09-15
Living with type 2 diabetes (T2D) may double the risk of developing sepsis—with those aged younger than 60 years and men particularly susceptible, according to a long-term community-based study in Australia, being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept). "An association between type 2 diabetes and sepsis has been noted in some earlier studies," said lead author Professor Wendy Davis from the University of Western Australia, Australia. "Our study, in a large community-based ...

New quantum sensors can withstand extreme pressure

2025-09-15
By Chris Woolston The world of quantum physics is already mysterious, but what happens when that strange realm of subatomic particles is put under immense pressure? Observing quantum effects under pressure has proven difficult for a simple reason: Designing sensors that can withstand extreme force is challenging. In a significant advance, a team led by physicists at WashU has created quantum sensors in an unbreakable sheet of crystallized boron nitride. The sensors can measure stress and magnetism in materials under pressure that exceeds 30,000 times the pressure of the ...

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

2025-09-15
Embargoed for release until 5:00 p.m. ET on Monday 15 September 2025    Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin              Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.    ----------------------------     1. ...

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

2025-09-15
•    Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients •    For eligible and willing patients, bariatric surgery provides the best option from a clinical and economic perspective A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, ...

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

2025-09-15
UNIVERSITY PARK, Pa. — The more interactive a mobile app or artificial intelligence (AI) chatbot is, the more playful they are perceived to be, with users letting their guard down and risking their privacy, according to a team led by researchers at Penn State. The researchers studied the effect of mobile app interactivity on users’ vigilance toward privacy risks during the sign-up process, and how this shapes their attitudes toward the app and their willingness to keep using it. The team found that interactivity motivates users to engage with the app by fostering a heightened sense of playfulness and lowering their privacy ...

LAST 30 PRESS RELEASES:

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

PFAS presence confirmed in the blood of children in Gipuzkoa

Why do people believe lies?

SwRI installs private 5G network for research, development, testing and evaluation

A new perspective in bone metabolism: Targeting the lysosome–iron–mitochondria axis for osteoclast regulation

[Press-News.org] CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025
Immersive experience will equip clinicians with the skills to harness AI in cardiovascular medicine